2,380
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Blood pressure phenotypes based on ambulatory monitoring in a general middle-aged population

, , , &
Pages 237-249 | Received 10 Jan 2021, Accepted 10 Mar 2021, Published online: 02 Apr 2021

References

  • Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–2260.
  • Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–968.
  • Collaboration N. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389(10064):37–55.
  • Williams B, Mancia G, Spiering W, et al.; ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
  • Sundstrom J, Neal B. Replacing the hypertension control paradigm with a strategy of cardiovascular risk reduction. Eur Heart J Qual Care Clin Outcomes. 2015;1(1):17–22.
  • Parati G, Stergiou G, O'Brien E, et al.; European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability. European society of hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32(7):1359–1366.
  • Ringrose JS, Bapuji R, Coutinho W, et al. Patient perceptions of ambulatory blood pressure monitoring testing, tolerability, accessibility, and expense. J Clin Hypertens (Greenwich). 2020;22(1):16–20.
  • Keren S, Leibowitz A, Grossman E, et al. Limited reproducibility of 24-h ambulatory blood pressure monitoring. Clin Exp Hypertens. 2015;37(7):599–603.
  • Bo Y, Kwok KO, Chung VC, et al. Short-term reproducibility of ambulatory blood pressure measurements: a systematic review and meta-analysis of 35 observational studies. J Hypertens. 2020;38(11):2095–2109.
  • WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate hyperglycaemia. 2006.
  • Bjork J, Grubb A, Sterner G, et al. Revised equations for estimating glomerular filtration rate based on the Lund-Malmo Study cohort. Scand J Clin Lab Invest. 2011;71(3):232–239.
  • Bjork J, Jones I, Nyman U, et al. Validation of the Lund-Malmo, Chronic Kidney Disease Epidemiology (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) equations to estimate glomerular filtration rate in a large Swedish clinical population. Scand J Urol Nephrol. 2012;46(3):212–222.
  • WHO. Waist circumference and waist – hip ratio: report of a WHO expert consultation. 2008.
  • Ware A, Stevens R, Selwood M, et al. Accuracy of blood pressure monitors available in high street pharmacies. Blood Press Monit. 2016;21(1):59–61.
  • Sundstrom J, Lind L, Lampa E, et al. Weight gain and blood pressure. J Hypertens. 2020;38(3):387–394.
  • Aboyans V, Criqui MH, Abraham P, et al.; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890–2909.
  • Karjalainen T, Adiels M, Bjorck L, et al. An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk: the Northern Sweden MONICA Study 1999-2014. Eur J Prev Cardiolog. 2017;24(1):103–110.
  • Frigy A, Varga I, Fogarasi Z, et al. The influence of sleep apnea on 24-hour and nocturnal ECG and blood pressure parameters in patients with acute heart failure. Med Princ Pract. 2019;28(2):150–157.
  • Fagard R, Brguljan J, Thijs L, et al. Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis. J Hypertens. 1996;14(5):557–563.
  • Staessen JA, O'Brien ET, Amery AK, et al. Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database. J Hypertens Suppl. 1994;12(7):S1–S12.
  • Octavio JA, Contreras J, Amair P, et al. Time-weighted vs. conventional quantification of 24-h average systolic and diastolic ambulatory blood pressures. J Hypertens. 2010;28(3):459–464.
  • Bilo G, Giglio A, Styczkiewicz K, et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of nocturnal blood pressure fall. J Hypertens. 2007;25(10):2058–2066.
  • Mena L, Pintos S, Queipo NV, et al. A reliable index for the prognostic significance of blood pressure variability. J Hypertens. 2005;23(3):505–511.
  • Musameh MD, Nelson CP, Gracey J, et al. Determinants of day-night difference in blood pressure, a comparison with determinants of day-time and night-time blood pressure. J Hum Hypertens. 2017;31(1):43–48.
  • Birkenhager AM, van den Meiracker AH. Causes and consequences of a non-dipping blood pressure profile. Neth J Med. 2007;65(4):127–131.
  • Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–2219.
  • NCGC. National institute for health and clinical excellence: guidance. In: Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34. London, UK: Royal College of Physicians; 2011.
  • Leung AA, Daskalopoulou SS, Dasgupta K, et al. Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults. Can J Cardiol. 2017;33(5):557–576.
  • Anstey DE, Pugliese D, Abdalla M, et al. An update on masked hypertension. Curr Hypertens Rep. 2017;19(12):94.
  • Head GA. Ambulatory blood pressure monitoring is ready to replace clinic blood pressure in the diagnosis of hypertension: pro side of the argument. Hypertension. 2014;64(6):1175–1181.
  • Reino-Gonzalez S, Pita-Fernandez S, Cibiriain-Sola M, et al. Validity of clinic blood pressure compared to ambulatory monitoring in hypertensive patients in a primary care setting. Blood Press. 2015;24(2):111–118.
  • Lovibond K, Jowett S, Barton P, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011;378(9798):1219–1230.
  • Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370(9594):1219–1229.
  • Fagard RH, Celis H, Thijs L, et al. Day-time and night-time blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51(1):55–61.
  • Siu AL, Force USPST. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;163(10):778–786.
  • O'Brien E, Parati G, Stergiou G, et al.; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731–1768.
  • Yang WY, Melgarejo JD, Thijs L, et al.; for The International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators. Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA. 2019;322(5):409–420.
  • Asayama K, Thijs L, Li Y, et al. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population. Hypertension. 2014;64(5):935–942.
  • Wang YC, Shimbo D, Muntner P, et al. Prevalence of masked hypertension among US adults with nonelevated clinic blood pressure. Am J Epidemiol. 2017;185(3):194–202.
  • Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24(1):52–58.
  • Melgarejo JD, Maestre GE, Thijs L, et al. Prevalence, treatment, and control rates of conventional and ambulatory hypertension across 10 populations in 3 continents. Hypertension. 2017;70(1):50–58.
  • Omboni S, Aristizabal D, De la Sierra A, et al. Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study. J Hypertens. 2016;34(11):2187–2198.
  • Hodgkinson J, Mant J, Martin U, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621.
  • Thakkar HV, Pope A, Anpalahan M. Masked hypertension: a systematic review. Heart Lung Circ. 2020;29(1):102–111.
  • de la Sierra A, Gorostidi M, Banegas JR, et al. Nocturnal hypertension or nondipping: which is better associated with the cardiovascular risk profile? Am J Hypertens. 2014;27(5):680–687.
  • Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and “white-coat” hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol. 2005;46(3):508–515.
  • de la Sierra A, Banegas JR, Vinyoles E, et al. Prevalence of masked hypertension in untreated and treated patients with office blood pressure below 130/80 mm Hg. Circulation. 2018;137(24):2651–2653.
  • Kario K, Thijs L, Staessen JA. Blood pressure measurement and treatment decisions. Circ Res. 2019;124(7):990–1008.
  • Wang C, Zhang J, Li Y, et al. Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease. Int J Cardiol. 2017;230:33–39.
  • Mwasongwe S, Min YI, Booth JN, et al. Masked hypertension and kidney function decline: the Jackson Heart Study. J Hypertens. 2018;36(7):1524–1532.
  • Shimbo D, Abdalla M, Falzon L, et al. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med. 2015;163(9):691–700.
  • Salles GF, Reboldi G, Fagard RH, et al. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 2016;67(4):693–700.
  • Hansen TW, Thijs L, Li Y, et al. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension. 2010;55(4):1049–1057.
  • Pierdomenico SD, Di Nicola M, Esposito AL, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens. 2009;22(8):842–847.